Premium
[P‐176]: Preclinical basis for the efficacy of memantine in Alzheimer's disease
Author(s) -
Banerjee Pradeep K.,
Lahiri Debomoy K.,
Tanila Heikki,
Miguel-Hidalgo Jose Javier,
Iqbal Khalid
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.237
Subject(s) - memantine , nmda receptor , pharmacology , neurotoxicity , excitotoxicity , long term potentiation , medicine , chemistry , receptor , toxicity
MEMANTINE IN ALZHEIMER’S DISEASE Pradeep K. Banerjee, Debomoy K. Lahiri, Heikki Tanila, Jose Javier Miguel-Hidalgo, Khalid Iqbal; Forest Research Institute, Jersey City, NJ, USA; Indiana University School of Medicine, Indianapolis, IN, USA; University of Kuopio, Kuopio, Finland; University of Mississippi Medical Center, Jackson, MS, USA; New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA